Morphological characterization of microglial states in human brain

PRIMARY OUTCOME

morphological classification of microglial states

EXPECTED OUTCOMES

Quantitative predictions: (1) Young adults: 85-90% ramified microglia, 5-8% amoeboid, 3-5% phagocytic, <2% dystrophic. Sholl: peak intersections 8-12 at 20 μm radius. (2) Aged normal: 60-70% ramified, 10-15% amoeboid, 8-12% phagocytic, 10-15% dystrophic. Sholl: peak decreases to 5-8, shifted to 15 μm (less branching, shorter processes). (3) AD cases: 40-50% ramified, 20-25% amoeboid (activated), 15-20% phagocytic (plaques), 15-20% dystrophic. Hippocampus more affected than cortex. (4) PD cases (substantia nigra): 30-40% ramified, 25-30% amoeboid, 20% phagocytic (neuromelanin uptake), 15-20% dystrophic. (5) Dystrophic microglia markers: 70-80% p16INK4a+, 60-70% 4-HNE+, 90% lipofuscin+ (autofluorescence). (6) Correlation: Dystrophic microglia % correlates with age (R=0.7, p<0.001) and disease severity (Braak stage, R=0.6).

SUCCESS CRITERIA

Primary: Significant difference in microglial morphology distribution across groups (chi-square test, p<0.001). Aged/diseased brains show >2-fold increase in dystrophic microglia vs. young adults (p<0.01, Dunn post-hoc). Secondary: (1) Ramified microglia decrease with age/disease (linear trend, p<0.01). (2) Sholl analysis: peak intersections and process length decrease with age (p<0.01, mixed-effects model). (3) Dystrophic microglia: >60% express p16INK4a (senescence marker, p<0.001 vs. ramified). (4) Regional specificity: Hippocampus in AD shows more phagocytic microglia than cortex (p<0.05). Substantia nigra in PD shows most dystrophic (p<0.05 vs. cortex). (5) Interrater reliability: Kappa >0.8 for morphological classification (2 independent raters on 20% of data). (6) Reproducibility: Results consistent across 2 independent staining batches. Establishes morphological atlas for human microglial states.

PROTOCOL

Human brain tissue: Postmortem samples from (1) Cognitively normal young adults (20-40 years, n=10). (2) Cognitively normal aged (70-90 years, n=10). (3) AD patients (Braak V-VI, n=10). (4) PD patients (Braak α-syn stage 4-6, n=10). Regions: Frontal cortex (Brodmann area 9), hippocampus (CA1), substantia nigra (for PD). Sectioning: 40 μm free-floating sections, every 10th section. Immunohistochemistry: IBA1 (pan-microglial marker, 1:500, Wako), CD68 (phagocytic marker, 1:200), HLA-DR (activation marker, 1:100). DAB or fluorescence detection. Morphological classification: (1) Ramified: >3 primary processes, extensive branching, small soma (<10 μm). (2) Amoeboid: 0-1 process, large soma (>15 μm), rounded. (3) Phagocytic: CD68+ inclusions, enlarged soma, retracted processes. (4) Dystrophic: fragmented processes, cytoplasmic beading, deramified. Quantification: Use Sholl analysis (ImageJ plugin) for ramified microglia: count intersections at 5 μm radii from soma. Measure soma size, process length, branch points per cell. Analyze 50 microglia per region per case (random sampling). Senescence markers: Co-stain for p16INK4a (senescence), 4-HNE (oxidative damage), lipofuscin (autofluorescence at 488/650 nm). Count dystrophic microglia positive for each marker. Statistics: Mixed-effects model with age/disease as fixed effect, subject as random effect. n=10 per group for 80% power to detect 30% difference.

LINKED HYPOTHESES

HTML iframe

<iframe src="http://scidex.ai/artifact/exp-dfe1aa55-056f-4da6-a6ca-4387de59fec6?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>

Markdown link

[Morphological characterization of microglial states in human brain](http://scidex.ai/artifact/exp-dfe1aa55-056f-4da6-a6ca-4387de59fec6)

Direct URL

http://scidex.ai/artifact/exp-dfe1aa55-056f-4da6-a6ca-4387de59fec6

Preview